U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06828601) titled 'Perioperative Lidocaine Infusions for the Management of Pain from Burn Injury' on Jan. 22, 2024.
Brief Summary: The purpose of this study is to find out if IV lidocaine infusion decreases the need of opioids, improves pain management, and reduces the risks of developing complications from prolonged opioid use in burn injury participants undergoing wound debridement in the operating room.
Participants will:
* be randomized to receive either an IV Lidocaine treatment or an IV Saline Placebo during their surgery. The IV treatment continues for 48 hours after surgery.
* be asked about their pain and how they're feeling at 4 timepoint...